Evidence map›Paper›PMID 24646733›Full record

ArticleCell cycle (Georgetown, Tex.)2014

Vhs2 is a novel regulator of septin dynamics in budding yeast.

Corinne Cassani, Erica Raspelli, Elena Chiroli, Roberta Fraschini

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 90% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. The Multiple Roles of the Cdc14 Phosphatase in Cell Cycle Control.International journal of molecular sciences · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Corinne CassaniUniversità degli Studi di Milano-Bicocca; Dipartimento di Biotecnologie e Bioscienze; Milano, Italy.
Erica RaspelliUniversità degli Studi di Milano-Bicocca; Dipartimento di Biotecnologie e Bioscienze; Milano, Italy.
Elena ChiroliIFOM - Istituto FIRC di Oncologia Molecolare; Milano, Italy.
Roberta FraschiniUniversità degli Studi di Milano-Bicocca; Dipartimento di Biotecnologie e Bioscienze; Milano, Italy.
FIRC Institute of Molecular Oncology · ITIstituto Nazionale di Fisica Nucleare, Sezione di Milano · ITUniversity of Milan · ITUniversity of Milano-Bicocca · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In budding yeast, septins are assembled into structures that undergo dramatic changes during the cell cycle. The molecular mechanisms that drive these remodelings are not fully uncovered. In this study, we describe a characterization of Vhs2, a nonessential protein that revealed to be a new player in septin dynamics. In particular, we report that Vhs2 is important to maintain the stability of the double septin ring structure until telophase. In addition, we show that Vhs2 undergoes multiple phosphorylations during the cell cycle, being phosphorylated during S phase until nuclear division and dephosphorylated just before cell division. Importantly we report that cyclin-dependent protein kinase Cdk1 and protein phosphatase Cdc14 control these Vhs2 post-translational modifications. These results reveal that Vhs2 is a novel Cdc14 substrate that is involved in the control of septin organization.

Indexed as

CDC2 Protein KinaseCell CycleCell Cycle ProteinsProtein Tyrosine PhosphatasesSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsSeptinsTelophaseCDC14 protein, S cerevisiaeCDC2 Protein KinaseCell Cycle ProteinsProtein Tyrosine PhosphatasesSaccharomyces cerevisiae ProteinsSeptinsCdc14phosphorylationseptinVhs2yeast

Identifiers

PMID24646733
PMCPMC4050164
OpenAlexW2072776118

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.